Insulin inhaler could become alternative for Type 1 diabetes insulin injections

Article excerpt

Researchers have developed an insulin inhaler that could spare Type 1 diabetes patients from daily injections, offering a potential breakthrough for millions of Americans. The inhalable form of insulin appears to work as effectively as traditional injected insulin, according to the medical research being highlighted. The development addresses a long-standing burden for diabetics who currently manage their condition through multiple daily needle injections. If approved, the inhaler could significantly improve quality of life and medication adherence among Type 1 diabetes patients. The innovation represents a shift in how insulin therapy is delivered, moving away from injection-dependent treatment protocols that have dominated diabetes management for decades.